Figure 2. The correlation between DARS2 expression and clinicopathological parameters in patients with esophageal carcinoma (ESCA). The correlation between the expression level of DARS2 and (A) age, (B) gender, (C) BMI, (D) pathologic stage, (E) T stage, (F) N stage, (G) M stage, (H) histological staging and (I) histologic grade.